and a high Follicular Lymphoma International Prognostic Index (FLIPI) score were associated with an increased risk of POD24. Finally, an analysis from the Lymphoma Epidemiology of Outcomes ...

Long-term results from a randomized trial confirmed that early rituximab monotherapy for advanced-stage, asymptomatic, low ...

Watchful waiting—also known as active surveillance—is a common approach for asymptomatic, advanced stage follicular lymphoma, ...

Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

Findings from the National LymphoCare Study provide insights into national practice patterns for patients with early follicular lymphoma and the role of watchful waiting. Risk stratification in ...

Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers—follicular lymphoma and marginal zone ...